multiple-sclerosis

Documents about multiple-sclerosis

• Identifying and Managing Psychological Distress in Multiple Sclerosis: The COMPASS-MS Study#831962ClinicalTrials.gov
• Neuromuscular Electrical Stimulation and Mobility in Multiple Sclerosis#840435ClinicalTrials.gov
• Stress Urinary Incontinence in Women With Multiple Sclerosis#843757ClinicalTrials.gov
• Sleep Apnea in Multiple Sclerosis Positive Airway Pressure Trial#845903ClinicalTrials.gov
• Effect of Acetominophen an Gait Fatigue in Multiple Sclerosis#848175ClinicalTrials.gov
• Body Weight Supported Treadmill Training in Persons With Multiple Sclerosis#850537ClinicalTrials.gov
• Acute Effects of Walking Exercise on Brain Functioning in Multiple Sclerosis#854965ClinicalTrials.gov
• Efficacy and Safety of Yishen Daluo Yin Granule for Relapsing-Remitting Multiple Sclerosis#864346ClinicalTrials.gov
• Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Associated With Multiple Sclerosis#864683ClinicalTrials.gov
• Multiple Sclerosis and Heavy Progressive Resistance Training#870040ClinicalTrials.gov
• Evaluation of Clinical, Morphologic and Biochemical Markers in Multiple Sclerosis#882777ClinicalTrials.gov
• Study to Investigate the Immune Response to Influenza Vaccine in Patients With Multiple Sclerosis on Teriflunomide#883460ClinicalTrials.gov
• Silodosin for Urinary Symptoms in Female Patients With Multiple Sclerosis#885304ClinicalTrials.gov
• Evaluate the Safe and Effective Use of the Avonex® Single-Use Autoinjector in Multiple Sclerosis Subjects#894492ClinicalTrials.gov
• Intensity Depended Impacts on Cognitive Functions in Persons With Multiple Sclerosis - a Pilot Study#896283ClinicalTrials.gov
• Yoga: Effect on Attention in Aging & Multiple Sclerosis#899008ClinicalTrials.gov
• Does Fampridine SR Improve Cognitive Fatigue in Multiple Sclerosis Patients?#899774ClinicalTrials.gov
• Association Between Fatigue and Balance in Patients With Multiple Sclerosis#902521ClinicalTrials.gov
• Comparison of Two Community Based Exercise Protocols in People With Multiple Sclerosis#904599ClinicalTrials.gov
• Dietary adherence and disability evolution in multiple sclerosis: an exploratory 12-month prospective cohort study#387893Gestión del Repositorio Documental de la Universidad de Salamanca
• Clinical Trial Assessing Temelimab Following Rituximab Treatment in Patients With Relapsing Forms of Multiple Sclerosis#801703ClinicalTrials.gov
• Study of Nighttime Dosing of Sublingual Tizanidine (12 mg) in Multiple Sclerosis (MS) Patients With Significant Spasticity#864731ClinicalTrials.gov
• Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents With Relapsing Remitting Multiple Sclerosis#879442ClinicalTrials.gov
• Long-term effectiveness of natalizumab in secondary progressive multiple sclerosis: A propensity-matched study#476137IRIS
• Over reliance on prior expectations in relapsing remitting multiple sclerosis#780639Europe PMC
• Immunoadsorption Versus High-dose Intravenous Corticosteroids in Relapsing Multiple Sclerosis#801587ClinicalTrials.gov
• Validation of Ella Platform for Serum Nfl And GFAP Measures In Multiple Sclerosis Patients#858013ClinicalTrials.gov
• Swiss Multiple Sclerosis Cohort-Study#875779ClinicalTrials.gov
• The Effect of Obesity on Contralateral Suppression in Patients With Multiple Sclerosis#875922ClinicalTrials.gov
• Multiple Sclerosis and Respiratory and Functional Capacity#888476ClinicalTrials.gov
• Acute Effect of Fascial Mobilization on Gait in Patients With Multiple Sclerosis#891962ClinicalTrials.gov
• The Effect of Levetiracetam (Keppra) on the Treatment of Tremor in Multiple Sclerosis#903437ClinicalTrials.gov
• Robot-assisted Gait Training on Mobility in Severely Disabled Multiple Sclerosis Patients#909604ClinicalTrials.gov
• REbif FLEXible Dosing in Early Multiple Sclerosis (MS)#967715ClinicalTrials.gov
• Effect of Low Histamine-Based Modified Mediterranean Diet in Multiple Sclerosis#800560ClinicalTrials.gov
• Safety and Efficacy Extension Study of Daclizumab High Yield Process (DAC HYP) (BIIB019) in Participants Who Have Completed Study 205MS202 (NCT00870740) to Treat Relapsing Remitting Multiple Sclerosis#842634ClinicalTrials.gov
• Effect of CoDuSe Balance Training and Step Square Exercises on Risk of Fall in Multiple Sclerosis#856051ClinicalTrials.gov
• The Effect of Emotional Freedom Technique on Depression, Anxiety and Distress of Individuals With Multiple Sclerosis#865809ClinicalTrials.gov
• Ifenprodil as a ReMyelinating repurpOsed Drug in Multiple Sclerosis#882395ClinicalTrials.gov
• A "negative"dendritic Cell-based Vaccine for the Treatment of Multiple Sclerosis: a First-in-human Clinical Trial#123567ClinicalTrials.gov
• Functional connectivity dynamics of monoaminergic circuits related to fatigue in multiple sclerosis#257188Europe PMC
• Short-term effects of ocrelizumab on cortical pathology in patients with multiple sclerosis#307864Europe PMC
• Normobaric Hypoxic Training and Multiple Sclerosis#827314ClinicalTrials.gov
• Effect of Sensory Integration Therapy on Gait Variability and Quality Of Life in Patients With Multiple Sclerosis#830556ClinicalTrials.gov
• Validating Digital Biomarkers to Detect Disease Activity and Disease Progression in Multiple Sclerosis#841944ClinicalTrials.gov
• Intervention for Young Adults With Multiple Sclerosis#859023ClinicalTrials.gov
• Promoting Physical Activity Behavior in Persons With Multiple Sclerosis#860050ClinicalTrials.gov
• Eszopiclone for Improving Sleep in Multiple Sclerosis (MS)#862553ClinicalTrials.gov
• The Effects of Respiratory-based Telerehabilitaion in Patients With MS#866290ClinicalTrials.gov
• The Effects of Muscles Strength on Physical Performance in Patients With Multiple Sclerosis#870909ClinicalTrials.gov